Plaquenil

How Hard Is It to Find Plaquenil in Stock?

Generic hydroxychloroquine is generally available from multiple manufacturers—including Dr. Reddy's, Amneal, and Mylan—making it accessible at most major pharmacy chains. However, localized supply gaps are common. Some manufacturers have discontinued their products (including Sun Pharma and specific Teva NDCs as of 2026), reducing the overall pool of suppliers and creating occasional regional shortages.

The most significant shortage in Plaquenil's history occurred in 2020, when unproven COVID-19 treatment claims sparked a massive demand spike that left lupus and RA patients unable to refill their prescriptions. While that acute crisis has passed, patients in some areas—especially rural communities or those who depend on a single pharmacy chain—may still encounter stock issues.

If you're having trouble filling your Plaquenil prescription, medfinder can help. We call pharmacies near you and text you which ones have your medication in stock—saving you hours of phone calls.

Who Can Prescribe Plaquenil?

Because Plaquenil is not a controlled substance, it can be prescribed by any licensed healthcare provider in the United States with prescribing authority—no special DEA registration or waiver is required. This makes it broadly accessible across a range of practice settings and provider types.

• Rheumatologists — Primary prescribers for lupus, RA, and related autoimmune conditions
• Dermatologists — Prescribe for cutaneous lupus (DLE, SCLE) and inflammatory skin conditions
• Primary Care Physicians / Internists — Often manage stable long-term hydroxychloroquine therapy after specialist initiation
• Nurse Practitioners (NPs) and Physician Assistants (PAs) — Can prescribe independently or with physician collaboration depending on state law
• Infectious Disease Specialists — Prescribe for malaria prevention in travelers

Telehealth prescribing is available in all 50 states for Plaquenil. Platforms such as Teladoc, MDLive, and specialized rheumatology telehealth practices can initiate and manage hydroxychloroquine therapy remotely, with in-person ophthalmology monitoring arranged separately for annual eye exams.

Is Plaquenil a Controlled Substance?

No. Plaquenil (hydroxychloroquine) is not a controlled substance. It has no DEA scheduling (Schedule I–V), meaning it can be prescribed by any licensed healthcare provider with prescribing authority, refilled without restriction, prescribed for 90-day supplies, and prescribed via telehealth without any additional federal requirements.

This is in contrast to medications like stimulants or opioids, which require special DEA registration to prescribe and are subject to refill limits, early fill restrictions, and mandatory in-person visits. Plaquenil has none of these restrictions. Patients on long-term therapy can request 90-day fills at retail or mail-order pharmacies, which reduces the frequency of refill challenges and is more cost-effective under most insurance plans.

Common Side Effects of Plaquenil

Most patients tolerate Plaquenil well. The most common side effects are gastrointestinal and typically improve over time, especially when the medication is taken with food or milk:

• Nausea, vomiting, and stomach upset
• Diarrhea or abdominal cramping
• Headache and dizziness
• Skin rash, itching, or mild pigmentation changes
• Insomnia

Serious Side Effects

Serious side effects are rare but can be severe. Seek immediate medical attention for any of the following:

• Retinal toxicity: Irreversible damage to the retina, especially with long-term use or doses >5 mg/kg/day; requires regular ophthalmology monitoring
• Cardiomyopathy and QT prolongation: Rare but potentially fatal; risk increases with QT-prolonging drugs like azithromycin
• Severe hypoglycemia: Enhanced blood sugar-lowering effect; monitor in diabetic patients
• Aplastic anemia / agranulocytosis: Rare blood cell suppression; higher risk in G6PD deficiency
• Stevens-Johnson Syndrome / DRESS: Life-threatening skin reactions; seek emergency care immediately

Final Thoughts on Plaquenil

Plaquenil (hydroxychloroquine) is a foundational medication for millions of Americans living with lupus and rheumatoid arthritis. Its favorable long-term safety profile, affordable generic pricing (as low as $15 with coupons), and broad prescribing access make it one of the most important tools in autoimmune disease management. Most patients who take it at appropriate weight-based doses with regular ophthalmology monitoring can do so safely for decades.

The main challenges in 2026 are localized supply gaps—not a nationwide shortage—and ensuring patients know how to find the medication when their usual pharmacy is out of stock. The key safety considerations are maintaining annual eye exams and being aware of serious drug interactions, particularly with QT-prolonging medications.

If you're struggling to find Plaquenil at your local pharmacy, medfinder can help. We call pharmacies near you and text you which ones have it in stock—so you can fill your prescription and stay on track with your treatment.